索拉非尼 Sorafenib Sorafenib is a synthetic compound targeting growth signaling and angiogenesis.
更新時間:2023-07-12
廠商性質:代理商
帕唑帕尼 Pazopanib Pazopanib is an approved drug, is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity.
更新時間:2023-07-12
廠商性質:代理商
樂伐替尼 Lenvatinib Lenvatinib,also known as E7080,is a synthetic,orally available inhibitor of vascular endothelial growth factor receptor 2(VEGFR2)tyrosine kinase with potential antineoplastic activity.
更新時間:2023-07-12
廠商性質:代理商
卡博替尼 Cabozantinib Cabozantinib, also known as XL-184 or BMS-907351, is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity.
更新時間:2023-07-12
廠商性質:代理商